|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Colo-Rectal Cancer
|
NCI
|
5R01CA104922-04
|
|
Phenolic antioxidants as tumor radio/chemosensitizers
|
KOUMENIS, CONSTANTINOS
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$261,121
|
|
Colo-Rectal Cancer
|
NCI
|
5R37CA055360-18
|
|
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINS
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$470,319
|
|
Colo-Rectal Cancer
|
NCI
|
5K01CA118425-03
|
|
Genetic and genomic analysis of Ras signaling in colorectal cancer progression
|
HAIGIS, KEVIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$162,964
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA076560-07
|
|
Thymidylate Synthases: Modes of Catalysis and Inhibition
|
LEBIODA, LUKASZ
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$163,827
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK054909-09
|
|
PKC ISOZYMES AND INTESTINAL EPITHELIAL GROWTH CONTROL
|
BLACK, JENNIFER
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$268,069
|
|
Colo-Rectal Cancer
|
NIGMS
|
5R37GM032741-26
|
|
INTRACHROMOSOMAL RECOMBINATION IN MAMMALIAN CELLS
|
LISKAY, R
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$354,186
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112438-03
|
|
Breaking tolerance to mEGP self-antigen
|
HERLYN, DOROTHEE
|
WISTAR INSTITUTE
|
PA
|
$197,513
|
|
Colo-Rectal Cancer
|
NIGMS
|
5R01GM050898-13
|
|
Mitotic Response to DNA damage
|
THEURKAUF, WILLIAM
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$499,975
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112337-04
|
|
Colon Cancer Inhibition by a Class of PPARgamma Agonists
|
SAFE, STEPHEN
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$226,255
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA120381-02
|
|
A Mediterranean Diet in for Colon Cancer Prevention
|
DJURIC, ZORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$367,050
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA084628-16
|
|
Telomerase in Development, Senescence and Neoplasia
|
DEPINHO, RONALD
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$578,964
|
|
Colo-Rectal Cancer
|
NIGMS
|
5F32GM076898-03
|
|
Mechanisms of Armadillo/Beta-catenin degradation
|
ROBERTS, DAVID
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$50,428
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA078814-10
|
|
New Triterpenoids for Cancer Chemoprevention & Therapy
|
SPORN, MICHAEL
|
DARTMOUTH COLLEGE
|
NH
|
$341,132
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA101988-05
|
|
Dual Compartmental Targeting of Cancer
|
GUSTAFSON, DANIEL
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$224,150
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA115513-02
|
|
TGF-beta signaling and colon cancer
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$339,257
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R37DK045370-11
|
|
Prevention and Treatment of Impotence
|
LUE, TOM
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$330,824
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA116576-02
|
|
Tailored Navigation in CRC Screening
|
MYERS, RONALD
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$530,038
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA098871-04
|
|
The Role of NF-kappaB in Chemotherapy Resistance
|
CUSACK, JAMES
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$340,162
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA121294-02
|
|
An Untested Approach: Biomarkers for Colon Cancer
|
MATTA, KHUSHI
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$145,505
|
|
Colo-Rectal Cancer
|
NCI
|
5R37CA043460-25
|
|
Molecular Genetic Analysis of Colorectal Cancer
|
VOGELSTEIN, BERT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$436,465
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA085700-07
|
|
OXIDATIVE PHOSPHORYLATION IN CELL GROWTH AND DEATH
|
MORAES, CARLOS
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$242,663
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA091576-09
|
|
Regulation of Ras activity by the p38 pathway
|
CHEN, GUAN
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$223,970
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA116573-02
|
|
Identifying Receipt of Colorectal Cancer Screening
|
PETERSON, NEERAJA
|
VANDERBILT UNIVERSITY
|
TN
|
$121,564
|
|
Colo-Rectal Cancer
|
NINDS
|
5R01NS021725-23
|
|
Regulation of Neuronal Synaptic Components
|
JACOB, MICHELE
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$358,502
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA118663-02
|
|
Storytelling for Colorectal Health among Latinos
|
LARKEY, LINDA
|
UNIVERSITY OF ARIZONA
|
AZ
|
$515,557
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK068366-03
|
|
Cdx2 modulates beta-catenin activity in intestinal cells
|
LYNCH, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$276,518
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA114264-03
|
|
Growth Factors, Curcumin and Colon Carcinogenesis
|
SINGH, POMILA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$208,202
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA067007-14
|
|
The Human Mismatch Repair Proteins and Carcinogenesis
|
FISHEL, RICHARD
|
OHIO STATE UNIVERSITY
|
OH
|
$365,836
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK043743-17
|
|
Intestinal Cell Growth Control: Role of Tyrosine Kinases
|
CARTWRIGHT, CHRISTINE
|
STANFORD UNIVERSITY
|
CA
|
$285,680
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK044525-14
|
|
Functions of the Brk Tyrosine Kinase in the Gastrointestinal Tract
|
TYNER, ANGELA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$311,395
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112390-04
|
|
Function of VEGF Receptor-1 on Colorectal Cancer Cells
|
ELLIS, LEE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$224,720
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA068124-13
|
|
Biomarkers of UC Tumorigenesis
|
BRENTNALL, TERESA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$353,217
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112278-04
|
|
Glycoside Inhibitors of Tumor Metastasis
|
ESKO, JEFFREY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$279,017
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA108741-03
|
|
TGF-beta pathway polymorphisms and colon cancer risk
|
PASCHE, BORIS
|
NORTHWESTERN UNIVERSITY
|
IL
|
$261,814
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA084197-10
|
|
Mechanisms of Intestinal Tumorigenesis
|
YANG, VINCENT
|
EMORY UNIVERSITY
|
GA
|
$370,797
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA131029-01
|
|
Fatigue, depression, and inflammation in cancer survivors: A prospective study
|
KIECOLT-GLASER, JANICE
|
OHIO STATE UNIVERSITY
|
OH
|
$864,589
|
|
Colo-Rectal Cancer
|
NCI
|
5U10CA020156-33
|
|
Primary Breast Cancer Therapy Group
|
MARGOLESE, RICHARD
|
SIR MORTIMER B. DAVIS JEWISH GEN HOSP
|
CANADA
|
$31,289
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA131378-01
|
|
Novel Sulindac Derivatives for Colon Cancer Chemoprevention
|
PIAZZA, GARY
|
SOUTHERN RESEARCH INSTITUTE
|
AL
|
$643,885
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA064462-12
|
|
GlcNAcT-V Regulation of Cell Surface Structure/Function
|
PIERCE, J
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$352,110
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112367-04
|
|
Improving Systems for Colorectal Cancer Screening
|
AYANIAN, JOHN
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$227,768
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA042857-20
|
|
Metastatic Potential of Colorectal Carcinoma
|
MISHRA, LOPA
|
GEORGETOWN UNIVERSITY
|
DC
|
$297,866
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA098497-06
|
|
Dietary Factors in the Etiology of Colorectal Cancer
|
YUAN, JIAN-MIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$297,587
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA092423-07
|
|
No-Releasing Aspirin and Colon Cancer Prevention
|
RIGAS, BASIL
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$328,058
|
|
Colo-Rectal Cancer
|
NCI
|
1R21CA131626-01
|
|
Colonoscopy in Rural Oregon Practice (CROP)
|
LIEBERMAN, DAVID
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$242,550
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA111914-04
|
|
Ovarian Cancer and Mismatch Repair Deficiency
|
PAL, TUYA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$414,533
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK071597-02
|
|
LPA receptor signaling in colonic epithelia
|
YUN, CHANGHYON
|
EMORY UNIVERSITY
|
GA
|
$307,377
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA081488-10
|
|
Molecular Epidemiology of Colorectal Cancer
|
GRUBER, STEPHEN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$923,263
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA098572-05
|
|
JC Virus and Tumor Formation in the Human Colon
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$260,276
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA039742-24
|
|
Epidemiology of Cancer in a Cohort of Older Women
|
FOLSOM, AARON
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$522,496
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA106269-04
|
|
VDR Variants, Nutrient Intakes, and Adenoma Recurrence
|
JACOBS, ELIZABETH
|
UNIVERSITY OF ARIZONA
|
AZ
|
$134,115
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA107028-04
|
|
Modeling Colon Cancer, Intervention and Prevention
|
LUEBECK, E
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$259,176
|
|
Colo-Rectal Cancer
|
NCI
|
1K05CA131504-01
|
|
Characterizing disease and treatment response in colon cancer chemoprevention
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$163,042
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA120870-03
|
|
Nutrient-Genome Interactions Involved in Colorectal Cancer
|
SOLOWAY, PAUL
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$141,904
|
|
Colo-Rectal Cancer
|
NCI
|
1K08CA131482-01
|
|
Oncolytic Vesicular Stomatitis Virus for the Treatment of Colorectal Cancer
|
STEWART, JOHN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$146,367
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA118992-03
|
|
Role of Gastrin in the Pathogenesis of Colorectal Cancer
|
WOLFE, M
|
BOSTON MEDICAL CENTER
|
MA
|
$249,738
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA065525-10
|
|
Modulation of Colon Carcinogenesis by Chlorophyllin
|
DASHWOOD, RODERICK
|
OREGON STATE UNIVERSITY
|
OR
|
$298,529
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112304-04
|
|
Colon Cancer Chemoprevention by Flavonoid Silibinin
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$288,389
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA069457-12
|
|
EMT regulation in gastrointestinal epithelial cells
|
BEAUCHAMP, ROBERT
|
VANDERBILT UNIVERSITY
|
TN
|
$272,145
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA119016-02
|
|
CRC Screening in Primary Care Settings: Factors for Low Income Urban Hispanics
|
DUHAMEL, KATHERINE
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$212,651
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA121851-02
|
|
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers
|
SPIEGELMAN, VLADIMIR
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$276,442
|
|
Colo-Rectal Cancer
|
NCI
|
5U10CA069651-15
|
|
Biostatistical Center for the NSABP
|
COSTANTINO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$3,800,453
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA065145-15
|
|
Genomic Imprinting in Cancer
|
FEINBERG, ANDREW
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$456,994
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA111469-04
|
|
COX-2 Inhibitors, APC and Colon Cancer Prevention
|
SUBBARAMAIAH, KOTHA
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$237,044
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA114569-03
|
|
The role of glutathione peroxidase in the pathogenesis of intestinal cancer
|
CHU, FONG-FONG
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$262,148
|
|
Colo-Rectal Cancer
|
NIA
|
5R01AG025834-02
|
|
Effects of aging and folate on colonic carcinogenesis
|
CHOI, SANG WOON
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$253,938
|
|
Colo-Rectal Cancer
|
NCI
|
1R15CA132093-01
|
|
Microsatellite variability within transcribed regions of genes involved in cancer
|
KOVACH, MARGARET
|
UNIVERSITY OF TENNESSEE CHATTANOOGA
|
TN
|
$201,154
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA123756-01A2
|
|
A Tumor Suppressor Function for the c-Fes Tyrosine Kinase in Colon Cancer
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$270,516
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA114467-03
|
|
Prostaglandin Synthesis, Genetics and Colorectal Cancer
|
ULRICH, CORNELIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$555,937
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA106348-05
|
|
Apoptotic Response to DNA Damage Initiated by PUMA
|
ZHANG, LIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$259,785
|
|
Colo-Rectal Cancer
|
NCI
|
2R01CA059034-14
|
|
Colonic Cytokinetics and Cell Signaling: Dietary Effects
|
CHAPKIN, ROBERT
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$276,812
|
|
Colo-Rectal Cancer
|
NHGRI
|
2R01CA059034-14
|
|
Colonic Cytokinetics and Cell Signaling: Dietary Effects
|
CHAPKIN, ROBERT
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$6,285
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA106577-04
|
|
5-LOX-1 and Clinical Chemoprevention of Colon Tumors
|
SHUREIQI, IMAD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$437,535
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA102303-05
|
|
Dendritics Cell Immunotherapy for Colorectal Cancer
|
FONG, LAWRENCE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$288,476
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA120523-01A2
|
|
A Prospective Study of Colorectal Cancer: One-Carbon Metabolism and Inflammation
|
ULRICH, CORNELIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$641,822
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA127659-01A1
|
|
Colonoscopy quality and outcomes in clinical practice
|
KO, CYNTHIA
|
UNIVERSITY OF WASHINGTON
|
WA
|
$361,061
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK061216-08
|
|
Epithelial-Mesenchymal Interactions in Gut Morphogenesis
|
RUBIN, DEBORAH
|
WASHINGTON UNIVERSITY
|
MO
|
$305,368
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA107011-05
|
|
PXR Controlled Bile Acid Detoxification in Colon Cancer
|
XIE, WEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$264,679
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA114075-04
|
|
Acoustic Radiation Force Imaging of Colorectal Tissues
|
NIGHTINGALE, KATHRYN
|
DUKE UNIVERSITY
|
NC
|
$280,299
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA046413-21
|
|
Role of EGFR Ligands in Neoplasia
|
COFFEY, ROBERT
|
VANDERBILT UNIVERSITY
|
TN
|
$556,959
|
|
Colo-Rectal Cancer
|
NIGMS
|
5R01GM057959-10
|
|
MECHANISM OF RAF-1 ACTIVATION
|
LUO, ZHIJUN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$277,343
|
|
Colo-Rectal Cancer
|
NCI
|
5F32CA117668-03
|
|
Mucosal Delivery Strategies for Cancer Vaccines
|
ZAHAROFF, DAVID
|
NATIONAL CANCER INSTITUTE
|
MD
|
$50,948
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA108697-04
|
|
Wnt signaling in Colon Cancer
|
WATERMAN, MARIAN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$276,029
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA123277-02
|
|
Using Targeted Immunotherapy to Enhance Chemotherapy of Colorectal Cancer
|
BEDI, ATUL
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$311,600
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA115783-01A2
|
|
Mismatch Repair Functions Affected During Tumorigenesis
|
HEINEN, CHRISTOPHER
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$241,696
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA122299-01A2
|
|
Vitamin D and Colorectal Cancer
|
BENYA, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$360,095
|
|
Colo-Rectal Cancer
|
NCI
|
2U01CA098710-05
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
GA
|
$1,063,219
|
|
Colo-Rectal Cancer
|
NCI
|
2U01CA098216-05
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
RIBOLI, ELIO
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
UK
|
$1,299,337
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA129383-01A1
|
|
Chemoprevention of Colorectal Cancer by Aldose Reductase Inhibition
|
SRIVASTAVA, SATISH
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$313,325
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA132317-01A2
|
|
Therapeutic Targeting of Wnt Signaling
|
WU, DIANQING
|
YALE UNIVERSITY
|
CT
|
$342,807
|
|
Colo-Rectal Cancer
|
NCI
|
5R37CA057030-20
|
|
Measurement Error, Nutrition and Breast/Colon Cancer
|
CARROLL, RAYMOND
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$309,549
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK052778-11
|
|
Function and Regulation of Gastrin
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$299,207
|
|
Colo-Rectal Cancer
|
NIDDK
|
2R01DK052334-11
|
|
Intestinal Growth Control
|
BEAUCHAMP, ROBERT
|
VANDERBILT UNIVERSITY
|
TN
|
$314,675
|
|
Colo-Rectal Cancer
|
NIA
|
5R01AG028730-02
|
|
SIRT as a regulator of health and lifespan of mammals
|
SINCLAIR, DAVID
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$339,521
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA115809-02
|
|
The role of GSTP1 in oncogenic K-Ras signaling
|
DANG, DUYEN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$147,840
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK058245-05
|
|
Colon Cell Differentiation: NAB and MUC2 Gene Expression
|
VELCICH, ANNA
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
NY
|
$223,889
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK054778-10
|
|
T cell activation and crypt cell apoptosis
|
BARRETT, TERRENCE
|
NORTHWESTERN UNIVERSITY
|
IL
|
$370,823
|
|
Colo-Rectal Cancer
|
NIDDK
|
1R21DK075944-01A2
|
|
Mechanisms of sensitzation in a rat model of chronic visceral hypersensitivity
|
WINSTON, JOHN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$226,500
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK073338-02
|
|
Role of Bacteria in Colitis-associated Colon Cancer
|
JOBIN, CHRISTIAN
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$293,314
|
|
Colo-Rectal Cancer
|
NCI
|
1R21CA127834-01A1
|
|
An Interactive Video Doctor to Encourage Cancer Screening
|
WALSH, JUDITH
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$167,706
|
|
Colo-Rectal Cancer
|
NIGMS
|
5R01GM065926-06
|
|
The biology of gastrin-ferric ion complexes
|
BALDWIN, GRAHAM
|
UNIVERSITY OF MELBOURNE
|
AUSTRA
|
$157,303
|
|
Colo-Rectal Cancer
|
NCI
|
1R21CA121066-01A2
|
|
Colorectal Cancer Screening in Southwestern Hispanics and Native Americans
|
RHYNE, ROBERT
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$170,100
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA113975-01A2
|
|
Role of Surface Roughness in Regulating Tumor Cell Behavior
|
GLOVER, SARAH
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$289,463
|
|
Colo-Rectal Cancer
|
NCI
|
5K24CA082450-08
|
|
Patient-oriented Research: Colon CA & Cancer Immunology
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$149,580
|
|
Colo-Rectal Cancer
|
NIDDK
|
1R21DK078946-01A1
|
|
Novel models for gastrointestinal disease, physiology and development
|
VAN DRIEL, IAN
|
UNIVERSITY OF MELBOURNE
|
AUSTRA
|
$138,352
|
|
Colo-Rectal Cancer
|
NCI
|
1R21CA122622-01A2
|
|
Role of Aldose Reductase-Like-1 in Colon Tumorigenesis
|
CAO, DELIANG
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
IL
|
$163,688
|
|
Colo-Rectal Cancer
|
NCI
|
2R01CA073674-10
|
|
Antioxidants and Antiinflammatory in Colorectal Cancer
|
KONG, AH-NG
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
NJ
|
$276,945
|
|
Colo-Rectal Cancer
|
NCI
|
2R01CA101135-05A1
|
|
Molecular Characterization of Cell-Cell Interactions in Cancer Metastasis
|
KONSTANTOPOULOS, KONSTANTINOS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$289,164
|
|
Colo-Rectal Cancer
|
NCRR
|
1S10RR024527-01
|
|
Tissue Arraying, Immunostaining, and Imaging System
|
KLEIN-SZANTO, ANDRES
|
FOX CHASE CANCER CENTER
|
PA
|
$263,546
|
|
Colo-Rectal Cancer
|
NIAID
|
5R01AI061701-04
|
|
Lymphoepithelial interactions in IBD
|
BARRETT, TERRENCE
|
NORTHWESTERN UNIVERSITY
|
IL
|
$322,767
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA107088-03
|
|
Bispecific Antibody Pretargeting for Therapy
|
SHARKEY, ROBERT
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
NJ
|
$512,569
|
|
Colo-Rectal Cancer
|
NCRR
|
1S10RR023709-01A1
|
|
PET for Molecular Imaging of Small Animals
|
THAKUR, MATHEW
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$500,000
|
|
Colo-Rectal Cancer
|
NIDDK
|
5K01DK077956-02
|
|
The role of ErbB-4 in inflammation-induced colon carcinogenesis
|
FREY, MARK
|
VANDERBILT UNIVERSITY
|
TN
|
$122,313
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA126037-02
|
|
A New Radiotracer for Sentinel Node Mapping of Colon Cancer
|
HOH, CARL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$185,400
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA125327-02
|
|
Nanoscale Functional Dendrimer-DNA Assemblies
|
GRINSTAFF, MARK
|
BOSTON UNIVERSITY
|
MA
|
$162,500
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA108956-04
|
|
The Role of p73 in Upper Gastrointestinal Carcinomas
|
ZAIKA, ALEXANDER
|
VANDERBILT UNIVERSITY
|
TN
|
$4,368
|
|
Colo-Rectal Cancer
|
NCI
|
5U01CA086389-09
|
|
EDRN: Clinical Epidemiology & Validation Centers
|
LYNCH, HENRY
|
CREIGHTON UNIVERSITY
|
NE
|
$643,459
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA121335-02
|
|
Molecular Analysis of CD44 on Colon Cancer Cells
|
SACKSTEIN, ROBERT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$332,500
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA122339-02
|
|
Epigenomic influences of diet on intestinal neoplasia
|
GREALLY, JOHN
|
YESHIVA UNIVERSITY
|
NY
|
$99,600
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA122334-02
|
|
Molecular mechanisms of Myc-induced tumor neovascularization
|
THOMAS-TIKHONENKO, ANDREI
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$299,250
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA109385-05
|
|
Dual-Modality System for Imaging Colon Cancer in Mice
|
BARTON, JENNIFER
|
UNIVERSITY OF ARIZONA
|
AZ
|
$249,900
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA054807-19
|
|
Autocrine TGF alpha-Function and Control in Colon Cancer
|
BRATTAIN, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$181,512
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA106780-03
|
|
Colorectal Cancer Decision Aids in Primary Care
|
DIAZ, JOSEPH
|
MEMORIAL HOSPITAL OF RHODE ISLAND
|
RI
|
$126,671
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA115436-04
|
|
Loci Affecting Colon Cancer Susceptibility
|
ELLIOTT, ROSEMARY
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$308,526
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112389-03
|
|
COLORECTAL CANCER SCREENING IN PRIMARY CARE PRACTICE
|
ORNSTEIN, STEVEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$388,728
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA102177-04
|
|
Dispositional Influences on Early Detection Behaviors
|
RISTVEDT, STEPHEN
|
WASHINGTON UNIVERSITY
|
MO
|
$130,151
|
|
Colo-Rectal Cancer
|
NCI
|
5U01CA086400-09
|
|
Great Lakes/New England Clinical Epidemiology/Validation
|
BRENNER, DEAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$1,145,611
|
|
Colo-Rectal Cancer
|
NCI
|
5R03CA128021-02
|
|
A novel sulindac derivative for colon cancer chemoprevention
|
PIAZZA, GARY
|
SOUTHERN RESEARCH INSTITUTE
|
AL
|
$110,049
|
|
Colo-Rectal Cancer
|
NCI
|
1R43CA132242-01
|
|
Adenoviral GFP targeting of metastatic human tumors using multiple delivery route
|
KISHIMOTO, HIROYUKI
|
ANTICANCER, INC.
|
CA
|
$149,575
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA074552-11
|
|
Measurement Error, Missing Data and Semiparametrics
|
WANG, NAISYIN
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$176,986
|
|
Colo-Rectal Cancer
|
NCI
|
1R43CA132396-01
|
|
Peclinical Studies on a Polyunsaturated Fatty acid-Taxoid Conjugate for IND Fili
|
GUPTA, RAMESH
|
CHEM-MASTER INTERNATIONAL, INC
|
NY
|
$99,109
|
|
Colo-Rectal Cancer
|
NCI
|
5R03CA128470-02
|
|
A PILOT INVESTIGATION OF ETHNIC DISPARITIES IN PATIENT-INITIATED PREMATURE TREATM
|
ADAMS, SWANN
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$72,000
|
|
Colo-Rectal Cancer
|
NCI
|
5R03CA123592-02
|
|
Tumor-associated small GTPase Rac1b: a putative biomarker for colon cancer
|
NIMNUAL, ANJARUWEE
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$77,500
|
|
Colo-Rectal Cancer
|
NCI
|
1R41CA132256-01
|
|
Endoscopically-guided optical coherence tomography for early cancer screening
|
IFTIMIA, NICUSOR
|
PHYSICAL SCIENCES, INC
|
MA
|
$149,825
|
|
Colo-Rectal Cancer
|
NCI
|
5R03CA127996-02
|
|
PPAR-gamma regulation of micro RNA metabolism in colon cancer
|
THOMPSON, E
|
MAYO CLINIC COLL OF MED, JACKSONVILLE
|
FL
|
$75,500
|
|
Colo-Rectal Cancer
|
NCI
|
1R41CA128362-01A1
|
|
Human Monoclonal Antibodies from Immunized Patient Lymphocytes
|
LIVINGSTON, PHILIP
|
MABVAX THERAPEUTICS, INC.
|
CA
|
$197,764
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA109269-05
|
|
Dietary Prevention of Cancer
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$274,345
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112237-04
|
|
Folate, Vitamin D and Calcium in Colorectal Cancer
|
HAILE, ROBERT
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$425,647
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA070337-12
|
|
Combination gene therapy for metastatic colon cancer
|
CHEN, SHU-HSIA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$287,106
|
|
Colo-Rectal Cancer
|
NIGMS
|
5R01GM073891-02
|
|
Cellular Functions of the Tumor Suppressor APC
|
MCCARTNEY, BROOKE
|
CARNEGIE-MELLON UNIVERSITY
|
PA
|
$251,104
|
|
Colo-Rectal Cancer
|
NCI
|
5K01CA104161-06
|
|
Excision Nucleases in Mismatch Repair and Tumorigenesis
|
ALAS, STEVE
|
CALIFORNIA STATE POLY U POMONA
|
CA
|
$143,246
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA067985-13
|
|
Recognition and Repair of Mismatched DNA by MutY
|
DAVID, SHEILA
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$227,808
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA111361-04
|
|
Oncogenic Ras, STAT1 and Chemoprevention
|
KLAMPFER, LIDIJA
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
NY
|
$208,961
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK055753-10
|
|
Prostaglandins in Epithelial Injury
|
STENSON, WILLIAM
|
WASHINGTON UNIVERSITY
|
MO
|
$284,340
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK062112-08
|
|
Nuclear Hormone Receptor in Intestinal Biology
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$309,386
|
|
Colo-Rectal Cancer
|
NCI
|
5U01CA114619-04
|
|
Deep South Network for Cancer Control
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$1,328,339
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112252-03
|
|
Anti-VEGF in Tumors & Wounds: Efficacy vs Toxicity
|
HURWITZ, HERBERT
|
DUKE UNIVERSITY
|
NC
|
$439,335
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA115983-03
|
|
Promoting Colon Cancer Screening Among African Americans
|
RAWL, SUSAN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$499,736
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA108610-05
|
|
Peroxisome Proliferator Activated Receptors in Lung Cancer
|
NEMENOFF, RAPHAEL
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$288,845
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA116467-03
|
|
Storytelling to Promote Colorectal Screening in Primary Care Clinics
|
LARKEY, LINDA
|
UNIVERSITY OF ARIZONA
|
AZ
|
$455,228
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA113831-04
|
|
Auto-Feedback Regulation of Beta-catenin in Human Cancer
|
LIU, BO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$250,280
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA121113-03
|
|
Large-scale Genetic Analyses of Gene Families in Colorectal Cancer
|
VELCULESCU, VICTOR
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$282,659
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA121176-02
|
|
Patient-reported Measures of Cultural and Linguistic Competence
|
NAPOLES-SPRINGER, ANNA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$216,184
|
|
Colo-Rectal Cancer
|
NIDDK
|
5K24DK002926-09
|
|
Gastrointestinal Cancer Prevention and Care
|
PROVENZALE, DAWN
|
DUKE UNIVERSITY
|
NC
|
$118,794
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA072851-13
|
|
The Biology and Diagnosis of Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
TX
|
$326,412
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA109256-05
|
|
Using NMD to identify Mutated genes in colon cancer
|
IONOV, YURIJ
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$328,360
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA081428-10
|
|
Molecular Characterization of ACF (Abberant Crypt Foci)
|
ROSENBERG, DANIEL
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$243,043
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA102695-04
|
|
Two Delivery Channels to Improve CRC Screening
|
WEINBERG, DAVID
|
FOX CHASE CANCER CENTER
|
PA
|
$453,574
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA116795-02
|
|
Oxidative Stress, DNA Repair & Colorectal Adenoma Risk
|
GOODMAN, MICHAEL
|
EMORY UNIVERSITY
|
GA
|
$286,379
|
|
Colo-Rectal Cancer
|
NCI
|
5U01CA084239-10
|
|
Prevention & Metastasis: Final Frontiers in Colon Cancer
|
COFFEY, ROBERT
|
VANDERBILT UNIVERSITY
|
TN
|
$1,051,364
|
|
Colo-Rectal Cancer
|
NCI
|
5U01CA114622-04
|
|
Appalachia Community Cancer Network
|
DIGNAN, MARK
|
UNIVERSITY OF KENTUCKY
|
KY
|
$1,057,654
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA118405-02
|
|
Regulation and Function of PTP-PEST in colon carcinoma
|
SASTRY, SARITA
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$286,900
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA043159-21
|
|
Enals in Tumorigenesis
|
CHUNG, FUNG-LUNG
|
GEORGETOWN UNIVERSITY
|
DC
|
$290,464
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA079572-09
|
|
Screening Colonoscopy Feasibility Trial
|
ZAUBER, ANN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$415,927
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA127745-02
|
|
Development of Noninvasive Bioluminescence Imaging for Cancer Diagnosis and Thera
|
SAYLER, GARY
|
UNIVERSITY OF TENNESSEE KNOXVILLE
|
TN
|
$121,384
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA114265-04
|
|
Nutritional mechanisms and intestinal tumorigenesis
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
NY
|
$249,388
|
|
Colo-Rectal Cancer
|
NCCAM
|
5R01AT003623-02
|
|
Colon Cancer Chemoprevention by Grape Seed Extract
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$257,981
|
|
Colo-Rectal Cancer
|
OD
|
5R01AT003623-02
|
|
Colon Cancer Chemoprevention by Grape Seed Extract
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$113,815
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R44DK068936-03
|
|
Colonoscope Force Monitor
|
SARVAZYAN, ARMEN
|
ARTANN LABORATORIES, INC.
|
NJ
|
$417,343
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA118235-03
|
|
Transplanted Stem Cells and Tumor Progression
|
WONG, MELISSA
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$265,423
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA127306-02
|
|
15-PGDH, A Novel in Vivo Suppressor of Colon Neoplasia in Mouse and Man
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$398,846
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112387-04
|
|
Enhancing Colorectal CA Screening through Learning Teams
|
CRABTREE, BENJAMIN
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
NJ
|
$107,627
|
|
Colo-Rectal Cancer
|
NCI
|
5U01CA114582-04
|
|
ATECAR: Asian Training, Education on Cancer & Research
|
MA, GRACE
|
TEMPLE UNIVERSITY
|
PA
|
$793,449
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA113932-04
|
|
Increasing Colorectal Cancer Screening in Rural Kentucky
|
DIGNAN, MARK
|
UNIVERSITY OF KENTUCKY
|
KY
|
$485,955
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA121105-02
|
|
SMAC in chemoprevention of colon cancer
|
ZHANG, LIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$272,659
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112081-05
|
|
Intestinal Cancer Chemoprevention: Molecular Mechanisms
|
YANG, WANCAI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$232,210
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA111947-04
|
|
A mouse model for p120 downregulation in cancer
|
REYNOLDS, ALBERT
|
VANDERBILT UNIVERSITY
|
TN
|
$287,369
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA118553-02
|
|
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$467,879
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA120122-02
|
|
"Using Perceptual Mapping to Develop Low Literacy CRC Screening Decision Aids"
|
GORDON, THOMAS
|
TEMPLE UNIVERSITY
|
PA
|
$180,000
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA081436-11
|
|
Role of Protein Kinase C in Colon Carcinogenesis
|
FIELDS, ALAN
|
MAYO CLINIC COLL OF MED, JACKSONVILLE
|
FL
|
$424,034
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA097325-05
|
|
Colon Cancer Pathways: Hyperplastic Polyps and Adenomas
|
NEWCOMB, POLLY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$760,236
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA103883-04
|
|
Cables and the colonocyte
|
ZUKERBERG, LAWRENCE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$284,164
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA085463-09
|
|
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$267,255
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA123473-02
|
|
FATTY ACID MODULATION OF COLON CELL TRANSFORMATION
|
AUGENLICHT, LEONARD
|
MONTEFIORE MEDICAL CENTER (BRONX, NY)
|
NY
|
$167,375
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA084138-07
|
|
Mox 1: A Novel Mitogenic Oxidase
|
LAMBETH, J.
|
EMORY UNIVERSITY
|
GA
|
$269,909
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA107345-04
|
|
Bile acid-induced colon cancer cell proliferation
|
RAUFMAN, JEAN-PIERRE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$213,890
|
|
Colo-Rectal Cancer
|
NCI
|
5U24CA114732-04
|
|
NSABP Biological Specimen Banks
|
WOLMARK, NORMAN
|
NSABP FOUNDATION, INC.
|
PA
|
$1,068,580
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA123245-02
|
|
Tailored Touchscreen Colorectal Cancer Prevention in Urban Core Clinics
|
GREINER, K
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$493,220
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA084202-08
|
|
Role of CEACAM1 in Epithelial Cell Polarization
|
SHIVELY, JOHN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$404,273
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA109220-05
|
|
Nuclear functions of the tumor suppressor protein APC
|
NEUFELD, KRISTI
|
UNIVERSITY OF KANSAS LAWRENCE
|
KS
|
$241,774
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA119014-03
|
|
RCT/Increase Colon Cancer Screening/Medicaid Managed Care
|
DIETRICH, ALLEN
|
DARTMOUTH COLLEGE
|
NH
|
$493,838
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA108664-04
|
|
Mammography Visits to Improve Colon Cancer Screening
|
CARLOS, RUTH
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$136,080
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA116468-04
|
|
APC and Retinoids in Zebrafish Enterocyte Development
|
JONES, DAVID
|
UNIVERSITY OF UTAH
|
UT
|
$251,966
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK059656-08
|
|
TGF-Beta Regulation of Intestinal Epithelial Cells
|
BARNARD, JOHN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$290,288
|
|
Colo-Rectal Cancer
|
NCI
|
5U10CA015488-36
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
HALLER, DANIEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$409,513
|
|
Colo-Rectal Cancer
|
NIEHS
|
5R21ES005633-02
|
|
PDRG, a novel p53 and DNA damage-regulated gene and colorectal cancer
|
SHEIKH, M
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$192,325
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA119087-03
|
|
Preventive of Bile Acid-Induced Colonic Oxidative DNA Damage
|
PAYNE, CLAIRE
|
UNIVERSITY OF ARIZONA
|
AZ
|
$260,253
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA113381-04
|
|
Study the Role of Chfr in Tumorigenesis
|
CHEN, JUNJIE
|
YALE UNIVERSITY
|
CT
|
$285,172
|
|
Colo-Rectal Cancer
|
NCI
|
5U01CA084313-10
|
|
Evolution of Primary and Resistant Solid Tumors
|
DEPINHO, RONALD
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$968,176
|
|
Colo-Rectal Cancer
|
NCI
|
5R37CA063585-16
|
|
MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPE
|
PERUCHO, MANUEL
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
CA
|
$826,306
|
|
Colo-Rectal Cancer
|
NCI
|
1R25CA126805-01A1
|
|
Improving compliance with colorectal cancer screening in family medicine residenc
|
PRICE, ROBERT
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$262,238
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA082402-07
|
|
Developing Virtual Colonoscopy for Cancer Screening
|
LIANG, JEROME
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$304,959
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA132660-01
|
|
Reducing disparities in colorectal cancer screening in Vietnamese Americans
|
NGUYEN, BANG
|
NORTHERN CALIFORNIA CANCER CENTER
|
CA
|
$599,078
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA108854-04
|
|
Role of IL10 and TGFb1 in colon cancer
|
ERDMAN, SUSAN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$242,697
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA104741-06
|
|
Ulcerative colitis-associated cancer and its prevention
|
YANG, GUANG-YU
|
NORTHWESTERN UNIVERSITY
|
IL
|
$216,840
|
|
Colo-Rectal Cancer
|
NIDDK
|
5K08DK074557-03
|
|
Ets transcription factors in intestinal biology
|
JEDLICKA, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$135,810
|
|
Colo-Rectal Cancer
|
FIC
|
1R03TW007963-01A1
|
|
Molecular Characterization of Sporadic Colorectal Cancer in the Young from India
|
POLLACK, JONATHAN
|
STANFORD UNIVERSITY
|
CA
|
$39,648
|
|
Colo-Rectal Cancer
|
NIDDK
|
5K08DK068026-04
|
|
Role of KLF6 in the DNA damage response and apoptosis
|
BANCK, MICHAELA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$128,655
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA104748-05
|
|
Surgical Studies of Signaling Pathways in GI Cancers
|
EVERS, BERNARD
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$293,511
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA114109-03
|
|
Bile Acid and Estrogen Receptors in Colon Cancer
|
KLIEWER, STEVEN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$270,593
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA095317-04
|
|
Novel anti-melanoma agents and their mechanism of action
|
JOSHI, HARISH
|
EMORY UNIVERSITY
|
GA
|
$257,865
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA116487-02
|
|
Enhancing Colorectal Cancer Screening in Primary Care
|
PASKETT, ELECTRA
|
OHIO STATE UNIVERSITY
|
OH
|
$504,396
|
|
Colo-Rectal Cancer
|
NCI
|
1R25CA132692-01
|
|
Training African American Peers as Patient Navigators for Colon Cancer Screening
|
REDD, WILLIAM
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$282,083
|
|
Colo-Rectal Cancer
|
NCI
|
7R01CA077398-11
|
|
CALIFORNIA TEACHERS STUDY
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$2,482,687
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA082223-10
|
|
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$280,202
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA132709-01
|
|
Focusing Implementation to Bring Effective Reminders: FIBER
|
FELDSTEIN, ADRIANNE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
CA
|
$595,203
|
|
Colo-Rectal Cancer
|
NCI
|
5F32CA128157-02
|
|
Total Synthesis of the Anticancer Natural Product Pachyclavulariaenone G
|
MATTSON, ANITA
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$46,826
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA108975-03
|
|
PPAR-gamma ligands in colorectal cancer
|
BAEK, SEUNG
|
UNIVERSITY OF TENNESSEE KNOXVILLE
|
TN
|
$199,929
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA132991-01
|
|
Polyphenon E for the Chemoprevention of Colorectal Cancer
|
SINICROPE, FRANK
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$635,500
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA044684-17
|
|
INFLAMMATION, OBESITY AND RISK OF COLORECTAL ADENOMAS
|
SANDLER, ROBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$543,098
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA112529-04
|
|
Hormones, hormone-related genes, and colorectal cancer
|
LIN, JENNIFER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$106,649
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R21DK071838-02
|
|
Dysbiosis in Inflammatory Bowel Disease
|
MUTLU, ECE
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$181,300
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA122451-02
|
|
Diet, Genetics, Epigenetics and Colorectal Adenoma Risk.
|
SHRUBSOLE, MARTHA
|
VANDERBILT UNIVERSITY
|
TN
|
$131,058
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA109332-05
|
|
Facilitating Informed Decisions for MSI Testing
|
MANNE, SHARON
|
FOX CHASE CANCER CENTER
|
PA
|
$488,974
|
|
Colo-Rectal Cancer
|
NCI
|
5R21CA117116-02
|
|
Reversal of 5-FU Resistance by Arsenic Trioxide in Colorectal Carcinoma
|
ARDALAN, BACH
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$290,700
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA071508-11
|
|
BIOLOGY AND PATHOLOGY OF A MODULATOR OF FGF
|
WELLSTEIN, ANTON
|
GEORGETOWN UNIVERSITY
|
DC
|
$280,788
|
|
Colo-Rectal Cancer
|
NCI
|
1R01CA132839-01
|
|
Fine-mapping of 8q24 and Loci Identified in Genome-Wide Studies for Breast & Colo
|
HAIMAN, CHRISTOPHER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$666,212
|
|
Colo-Rectal Cancer
|
NIDDK
|
1R01DK080805-01
|
|
c-Myc transcription in intestinal growth, differentiation, and carcinogenesis
|
YOCHUM, GREGORY
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$293,744
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA106996-05
|
|
Risk Perception/Communications/Reduction Behaviors
|
LOESCHER, LOIS
|
UNIVERSITY OF ARIZONA
|
AZ
|
$131,381
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112379-03
|
|
PHYSICIAN RECOMMENDATION AND COLORECTAL CANCER SCREENING
|
ELSTON LAFATA, JENNIFER
|
HENRY FORD HEALTH SYSTEM
|
MI
|
$294,241
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA113494-04
|
|
Molecular profiles of colorectal adenomas by array CGH
|
HOSTETTER, GALEN
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
AZ
|
$127,656
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA106296-05
|
|
Chemopreventive Effect of NSAIDs Against Prostate Cancer
|
NARAYANAN, BHAGAVATHI
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$295,647
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA112315-04
|
|
Spectroscopic Markers to Risk-Stratify Colonic Neoplasia
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
IL
|
$170,197
|
|
Colo-Rectal Cancer
|
NCI
|
5R03CA128096-02
|
|
Characterization of a putative GTP-binding protein as a novel tumor marker.
|
HUANG, YING
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$78,500
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA086357-09
|
|
Modulating Base Excision Repair in Tumor Drug Resistance
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$261,129
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA118794-02
|
|
Optically Monitoring Colon Microcirculation in Precancer
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
IL
|
$259,540
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK054942-08
|
|
Identifying colon cancer modifier genes with zebrafish
|
PACK, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$329,292
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA101830-04
|
|
Foundations of Pretargeted Radioimmunotherapy
|
WITTRUP, KARL
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$250,134
|
|
Colo-Rectal Cancer
|
NCI
|
5K01CA113413-03
|
|
ERalpha Regulation of Intestinal Homeostasis & Tumorigenesis
|
GOULD, KAREN
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$152,542
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA092447-07
|
|
Southern Community Cohort Study
|
BLOT, WILLIAM
|
VANDERBILT UNIVERSITY
|
TN
|
$5,456,051
|
|
Colo-Rectal Cancer
|
NCI
|
1R21CA133263-01
|
|
Thermochemical Ablation in Image-Guided Interventions: Initial Assessment
|
CRESSMAN, ERIK
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$162,486
|
|
Colo-Rectal Cancer
|
NIDDK
|
5K08DK070708-05
|
|
Role of Metalloproteinases in Colon Cancer Metastases
|
GORDEN, DAVID
|
VANDERBILT UNIVERSITY
|
TN
|
$124,038
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA120448-02
|
|
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes
|
STOFFEL, ELENA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$141,548
|
|
Colo-Rectal Cancer
|
NCI
|
1K22CA133186-01
|
|
Increasing primary care physician colorectal cancer screening rates
|
GUERRA, CARMEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$159,219
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA105038-04
|
|
APC Tumor Suppressor in Cell Differentiation and Death
|
AHMED, YASMATH
|
DARTMOUTH COLLEGE
|
NH
|
$239,551
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA100450-05
|
|
Thymineless stress, DNA repair and recombination
|
WYATT, MICHAEL
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$247,638
|
|
Colo-Rectal Cancer
|
NIDDK
|
5R01DK045496-16
|
|
PHYSIOLOGY AND CLONING OF B FRAGILIS ENTEROTOXIN
|
SEARS, CYNTHIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$319,921
|
|
Colo-Rectal Cancer
|
NCI
|
5K07CA107079-04
|
|
Patient Activation To Increase Colon Cancer Screening
|
KATZ, MIRA
|
OHIO STATE UNIVERSITY
|
OH
|
$135,108
|
|
Colo-Rectal Cancer
|
NIDDK
|
1K24DK080941-01
|
|
Improving Gastrointestinal Disease Outcomes in Vulnerable Populations
|
INADOMI, JOHN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$177,962
|
|
Colo-Rectal Cancer
|
NCI
|
2P50CA097248-06A1
|
0008
|
Role of Soy Isoflavones, Smoking Abstinence and Molecular Markers in Prevention
|
WOLF, GREGORY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$283,027
|
|
Colo-Rectal Cancer
|
NCI
|
5R01CA124763-02
|
|
The Role of Dopamine in Colon Cancer Neovascularization
|
BASU, SUJIT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$287,090
|
|
